sucroferric oxyhydroxide

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2018
024620142018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background Sucroferric oxyhydroxide is a non-calcium, iron-based phosphate binder indicated for the treatment of… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
Background: Iron-based phosphate binders are widely used in hemodialysis, to avoid the increased mortality associated with high… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2016
2016
BACKGROUND Many patients with chronic kidney disease are prescribed vitamin D receptor agonists (VDRAs) for the management of… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
2015
2015
BACKGROUND Hyperphosphatemia necessitates the use of phosphate binders in most dialysis patients. Long-term efficacy and… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
Elevated serum phosphorus, calcium, and fibroblast growth factor 23 (FGF23) levels are associated with cardiovascular disease in… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • table 3
Is this relevant?
2015
2015
2015 Sucroferric oxyhydroxide (Velphoro®; Vifor Fresenius Medical Care Renal Pharma Ltd) is an iron-based phosphate binder… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
2014
2014
BACKGROUND The novel iron-based phosphate binder sucroferric oxyhydroxide is being investigated for the treatment of… (More)
  • table 1
  • table 2
  • table 3
  • table 3
  • table 4
Is this relevant?
2014
2014
Efficacy of PA21 (sucroferric oxyhydroxide), a novel calcium-free polynuclear iron(III)-oxyhydroxide phosphate binder, was… (More)
Is this relevant?
Review
2014
Review
2014
Sucroferric oxyhydroxide (VELPHORO) is a polynuclear iron-based phosphate binder recently approved for the treatment of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?